PACE study: real-life Psoriasis Area and Severity Index (PASI) 100 response with biological agents in moderate-severe psoriasis-Reference-Cited by-同舟云学术

PACE study: real-life Psoriasis Area and Severity Index (PASI) 100 response with biological agents in moderate-severe psoriasis

Published:2017-11-10 Issue:5 Volume:29 Page:481-486
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Carrera Carlo Giovanni¹,Dapavo Paolo²,Malagoli Piergiorgio³,Naldi Luigi⁴,Arancio Luisa¹,Gaiani Francesca³,Egan Colin Gerard⁵,Di Mercurio Marco⁶,Cattaneo Angelo¹

Affiliation:

1. U.O. Dermatologia, Fondazione IRCCS Cà Granda – Ospedale Maggiore Policlinico, Milan, Italy;

2. Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy;

3. Dermatology Unit, Azienda Ospedaliera San Donato Milanese, Milan, Italy;

4. U.O.C. Dermatologia, Ospedale San Bortolo – Azienda ULSS8, Berica (VI), Italy;

5. CE Medical Writing, Pisa, Italy;

6. Division of Dermatology, Humanitas Research Hospital, Milan, Italy

Publisher

Informa UK Limited

Subject

Dermatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/09546634.2017.1395805

Reference43 articles.

1. Pathogenesis and clinical features of psoriasis

2. Psoriasis

3. Definition of treatment goals for moderate to severe psoriasis: a European consensus

4. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: Results from NHANES 2003-2004

5. Comorbidities in psoriasis

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors Associated With Achieving Complete Skin Clearance Compared to Almost Complete Skin Clearance in Patients With Moderate to Severe Psoriasis Treated With Biologics: A Retrospective Chart Review;Annals of Dermatology;2024

2. Achievement and maintenance of therapeutic response to brodalumab in patients with moderate‐to‐severe plaque psoriasis: An Italian, observational, retrospective and prospective study (BRIGHT study);JEADV Clinical Practice;2023-06-30

3. Quality of Life Benefit and Clinical Predictors of Complete Skin Clearance in Psoriasis: A Multicenter, Prospective, Real-World Study;Dermatology;2023

4. Direct Comparison of Real-world Effectiveness of Biologics for Psoriasis using Absolute and Relative Psoriasis Area and Severity Index Scores in a Prospective Multicentre Cohort;Acta Dermato-Venereologica;2022-05-16

5. Canadian Adalimumab Postmarketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis (COMPLETE-PsA): 12-month Results of Comparative Effectiveness of Adalimumab and nbDMARDs;The Journal of Rheumatology;2022-01-15